Infant Formula Supplemented with Five Human Milk Oligosaccharides Shifts the Fecal Microbiome of Formula-Fed Infants Closer to That of Breastfed Infants
Nutrients · 10.07.2023 · 15 (14) · 3087
DOI: 10.3390/nu15143087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 10.07.2023. Verfasst von Andrea Q Holst und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chr. Hansen A/S, 2970 Hoersholm, Denmark. Hauptthemen laut MEDLINE: Breast Feeding, Microbiota. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chr. Hansen HMO GmbH, Chr. Hansen A/S.
Abstract (Originalsprache)
Breastmilk is the optimal source of infant nutrition, with short-term and long-term health benefits. Some of these benefits are mediated by human milk oligosaccharides (HMOs), a unique group of carbohydrates representing the third most abundant solid component of human milk. We performed the first clinical study on infant formula supplemented with five different HMOs (5HMO-mix), comprising 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, 3′-sialyllactose and 6′-sialyllactose at a natural total concentration of 5.75 g/L, and here report the analysis of the infant fecal microbiome. We found an increase in the relative abundance of bifidobacteria in the 5HMO-mix cohort compared with the formula-fed control, specifically affecting bifidobacteria that can produce aromatic lactic acids. 5HMO-mix influenced the microbial composition as early as Week 1, and the observed changes persisted to at least Week 16, including a relative decrease in species with opportunistic pathogenic strains down to the level observed in breastfed infants during the first 4 weeks. We further analyzed the functional potential of the microbiome and observed features shared between 5HMO-mix-supplemented and breastfed infants, such as a relative enrichment in mucus and tyrosine degradation, with the latter possibly being linked to the aromatic lactic acids. The 5HMO-mix supplement, therefore, shifts the infant fecal microbiome closer to that of breastfed infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chr. Hansen A/S, 2970 Hoersholm, Denmark.
- Clinical Microbiomics, 2200 Copenhagen, Denmark.
- Chr. Hansen HMO GmbH, 53619 Rheinbreitbach, Germany.
ORCID-Profile: Cathrine Melsaether
Förderung
- Chr. Hansen HMO GmbH
- Chr. Hansen A/S
Zitieren
APA
Holst, A. Q., Myers, P., Rodríguez-García, P., Hermes, G. D. A., Melsaether, C., Baker, A., Jensen, S. R., & Parschat, K. (2023). Infant Formula Supplemented with Five Human Milk Oligosaccharides Shifts the Fecal Microbiome of Formula-Fed Infants Closer to That of Breastfed Infants. Nutrients, 15(14), 3087. https://doi.org/10.3390/nu15143087
Vancouver
Holst AQ, Myers P, Rodríguez-García P, Hermes GDA, Melsaether C, Baker A, et al. Infant Formula Supplemented with Five Human Milk Oligosaccharides Shifts the Fecal Microbiome of Formula-Fed Infants Closer to That of Breastfed Infants. Nutrients. 2023;15(14):3087. doi:10.3390/nu15143087
BibTeX
@article{Holst2023,
author = {Holst, Andrea Q and Myers, Pernille and Rodríguez-García, Paula and Hermes, Gerben D A and Melsaether, Cathrine and Baker, Adam and Jensen, Stina R and Parschat, Katja},
title = {Infant Formula Supplemented with Five Human Milk Oligosaccharides Shifts the Fecal Microbiome of Formula-Fed Infants Closer to That of Breastfed Infants},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {14},
pages = {3087},
doi = {10.3390/nu15143087}
}
EUVIMED